Clinical Trial Update: The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A trial update for CAPER, a Phase 1/2 study evaluating cyclophosphamide with pembrolizumab in metastatic renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: The Christie NHS Foundation Trust | Conditions: Metastatic Renal Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN